SHARE THIS:
Search for Santa Ana Bio Raises $168M inSeries A and B Funding to Advance Precision Medicines for Inflammatory Illneses - Next Digital Health in the web..
![SuPport-Desk_Does Norse have a 24-hour cancellation policy? - Google Ad Manager Community]( "SuPport-Desk_Does Norse have a 24-hour cancellation policy? - Google Ad Manager Community")
![[[ask^iberia]]How to communicate with Iberia? on TIDAL](https://resources.tidal.com/images/e9448a9a/3ade/4f79/93d2/12e6d8d4b2eb/1080x1080.jpg "[[ask^iberia]]How to communicate with Iberia? on TIDAL")
![24/7 QuickBooks Online Support – Call [8337432896] Anytime! - Introduce yourself to the community - Monetize.info Community](https://monetize.info/community/uploads/monthly_2024_06/monetizeInfo_cover.jpg.a3ca29c96742b09faf0c88dee7d81b62.jpg "24/7 QuickBooks Online Support – Call [8337432896] Anytime! - Introduce yourself to the community - Monetize.info Community")
Santa Ana Bio Raises $168M inSeries A and B Funding to Advance Precision Medicines for Inflammatory Illneses - Next Digital Health
A California-based precision immunology company, Santa Ana Bio, has emerged from stealth with a combined series A and B funding of $168 to deliver precision medicines for patients struggling with inflammatory diseases. According to the company’s announcement, the combined capital raised comprised $43 million in a Series A funding round led by Versant Ventures and Santa Ana Bio's latest capital infusion will help the company to advance precision medicines through 3 major programs ahead of clinical entry in 2025.
read more..
Search for Santa Ana Bio Raises $168M inSeries A and B Funding to Advance Precision Medicines for Inflammatory Illneses - Next Digital Health in the web..
Latest links